← All Gsk PLC filings

Gsk PLC 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NYSE
GSK
Gsk PLC
20-F: GSK Reports Strong 2025 Growth, Pipeline Advances, and Leadership Transition
GSK plc delivered robust financial performance in 2025 with significant sales and profit growth, driven by Specialty Medicines and key product approvals, alongside a smooth CEO transition and strategic pipeline investments.
NYSE
GSK
Gsk PLC
20-F: GSK plc Releases 2024 Annual Report, Highlights Pipeline Progress and Financial Performance
GSK plc's 2024 Annual Report showcases strong financial performance, pipeline advancements, and a commitment to responsible business practices.
NYSE
GSK
Gsk PLC
20-F: GSK Appoints Julie Brown as New CFO, Details Key Terms and Benefits
GSK Services Unlimited offers Julie Brown the role of Chief Financial Officer of GSK plc, outlining her duties, compensation, and benefits in a detailed employment contract.